The Department of Health and Human Services, specifically the National Institutes of Health (NIH), intends to award a sole source contract to Thermo Fisher Scientific for preventative maintenance services on thirty-one Sorvall Legend Centrifuges. The primary objective of this procurement is to ensure the continued operational integrity of critical laboratory equipment used in the manufacturing of cell-based therapies for patients enrolled in clinical trials, adhering to stringent FDA regulations. Given the importance of these centrifuges in supporting patient care and the potential risks associated with transitioning to a new vendor, the NIH emphasizes that only the original equipment manufacturer can perform necessary software updates and maintenance. Interested parties capable of providing similar services must submit a capability statement by November 17, 2024, to Sheri Eiri at sheri.eiri@nih.gov for consideration.